Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
SAPU NANO (US) LLC
University of Wisconsin, Madison
ITM Solucin GmbH
University of Miami
Imperial College London
Novelty Nobility, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Stanford University
Jonsson Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Peking University Cancer Hospital & Institute
Erasmus Medical Center
Legend Biotech USA Inc
Peter MacCallum Cancer Centre, Australia
Virogin Biotech Ltd.